Faculty profile

Marcel Behr

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Marcel Behr

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
2 publications in the last five years, latest in 2024.
Principal investigator on 11 research grants (9 CIHR, 2 NSERC), most recently in 2025.
Supervised 2 trainees who won CIHR awards, most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Tuberculosis Crc Aboriginal Health Bacterial Genomics Molecular Epidemiology Host-Bacterial Interactions Innate Immunity Mycobacteria

Latest papers

Whole genome sequencing of M. tuberculosis for disease control in high-burden settings: study protocol for a cluster randomized controlled trial evaluating different community-wide intervention strategies in rural Madagascar.
Trials · 2024
Implications of subclinical tuberculosis for vaccine trial design and global effect.
The Lancet. Microbe · 2024
Drivers of Tuberculosis Transmission.
The Journal of infectious diseases · 2017

All 8 publications

Latest funding

Canada Research Chair - Tier 1
CIHR · 2025 · Nominated PI
$1,400,000
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
CIHR · 2023 · Co-investigator
$1,154,425
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
CIHR · 2023 · Co-investigator
$4,617,694

All 25 grants and awards

8 publications.

Whole genome sequencing of M. tuberculosis for disease control in high-burden settings: study protocol for a cluster randomized controlled trial evaluating different community-wide intervention strategies in rural Madagascar.

Ametepe ESA, Andriamanoha N, Andrianomanana FR, Point F, Mangahasimbola RT, Dyachenko A, Hall M, Gamana TM, Knoblauch AM, Razafindrasoa YY, Nimalan A, Behr M, Durand M, Johri M, Iqbal Z, Rakotoarivelo AR, Randremanana RV, Rakotosamimanana N, Lapierre SG

Trials2024

DOI: 10.1186/s13063-024-08537-4 PMID: 39456079

Implications of subclinical tuberculosis for vaccine trial design and global effect.

Churchyard GJ, Houben RMGJ, Fielding K, Fiore-Gartland AL, Esmail H, Grant AD, Rangaka MX, Behr M, Garcia-Basteiro AL, Wong EB, Hatherill M, Mave V, Dagnew AF, Schmidt AC, Hanekom WA, Cobelens F, White RG

The Lancet. Microbe2024

DOI: 10.1016/s2666-5247(24)00127-7 PMID: 38964359

Drivers of Tuberculosis Transmission.

Mathema B, Andrews JR, Cohen T, Borgdorff MW, Behr M, Glynn JR, Rustomjee R, Silk BJ, Wood R

The Journal of infectious diseases2017

DOI: 10.1093/infdis/jix354 PMID: 29112745

Latent Mycobacterium tuberculosis Infection and Interferon-Gamma Release Assays.

Pai M, Behr M

Microbiology spectrum2016Senior author

DOI: 10.1128/microbiolspec.tbtb2-0023-2016 PMID: 27763261

Towards probabilistic decision support in public health practice: predicting recent transmission of tuberculosis from patient attributes.

Mamiya H, Schwartzman K, Verma A, Jauvin C, Behr M, Buckeridge D

Journal of biomedical informatics2015

DOI: 10.1016/j.jbi.2014.11.006 PMID: 25460204

TB: screening for responses to a vile visitor.

Behr M, Schurr E, Gros P

Cell2010First author

DOI: 10.1016/j.cell.2010.02.030 PMID: 20211131

Molecular genetic analysis of two loci (Ity2 and Ity3) involved in the host response to infection with Salmonella typhimurium using congenic mice and expression profiling.

Sancho-Shimizu V, Khan R, Mostowy S, Larivière L, Wilkinson R, Riendeau N, Behr M, Malo D

Genetics2007

DOI: 10.1534/genetics.107.075523 PMID: 17660555

Dwellings, crowding, and tuberculosis in Montreal.

Wanyeki I, Olson S, Brassard P, Menzies D, Ross N, Behr M, Schwartzman K

Social science & medicine (1982)2006

DOI: 10.1016/j.socscimed.2005.12.015 PMID: 16480805

Canada Research Chair - Tier 1

Nominated PICIHR2025Canada Research Chairs - CIHR Funded - Tier 1

Principal investigators: Behr, Marcel A

Keywords: Crc

$1,400,000

Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Menzies, Richard; Campbell, Jonathon; Fox, Gregory; Golchi, Shirin; Johnston, James C; Law, Stephanie; Long, Richard; Lupien, Andréanne; Ruslami, Rovina

Keywords: Acceptability; Adaptive Trial; Cost-Effectiveness; Multi-Arm Trial; Multicentre Trial; Randomized Trial; Safety; Tolerability; Tuberculosis; Tuberculosis Prevention

$1,154,425

Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects

Principal investigators: Menzies, Richard; Campbell, Jonathon; Fox, Gregory; Golchi, Shirin; Johnston, James C; Law, Stephanie; Long, Richard; Lupien, Andréanne; Ruslami, Rovina

Keywords: Acceptability; Adaptive Trial; Cost-Effectiveness; Multi-Arm Trial; Multicentre Trial; Randomized Trial; Safety; Tolerability; Tuberculosis; Tuberculosis Prevention

$4,617,694

Differential virulence within the Mycobacterium tuberculosis complex

Nominated PICIHR2022Project Grant

Principal investigators: Behr, Marcel A

Keywords: Pathogenesis; Tuberculosis

$1,147,500

The role of the Mycobacterium tuberculosis SigK regulon in infection and disease

SupervisorCIHR2019Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: Danchuk, Sarah N

Keywords: Antigenic Potential; Bacterial Genetics; Gene Knockout; Global Health; Infection Outcomes; Innate Immunity; Molecular Biology; Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species; Recombineering

$105,000

Resensitizing bacteria to itaconate as a new approach for the treatment of infections

Co-investigatorCIHR2019Project Grant

Principal investigators: Auclair, Karine

Keywords: Antibiotics; Enzyme Inhibition; Immunology

$780,300

Initial vancomycin taper for the prevention of recurrent Clostridium difficile infection

Co-investigatorCIHR2018Project Grant

Principal investigators: Lee, Todd C; McDonald, Emily G

Keywords: Clostridium Dificile; Prevention; Recurrence; Vancomycin

$378,676

Resensitizing intracellular bacteria to itaconate as a new approach for the treatment of Salmonella and Mycobacterial infections

Co-investigatorCIHR2018Project Grant - Priority Announcement: Antimicrobial Resistance

Principal investigators: Auclair, Karine

Keywords: Antibiotics; Antivirulence

$100,000

Canada Research Chair Tier 1

Nominated PICIHR2018Canada Research Chairs - CIHR Funded - Tier 1

Principal investigators: Behr, Marcel A

Keywords: Crc

$1,400,000

From Molecules to Patients to Policies Symposium

Co-investigatorCIHR2017Planning and Dissemination Grant - Institute Community Support

Principal investigators: Schurr, Erwin A

Keywords: Antimicrobial Resistance; Existing And Emerging Microbial Threats; Hiv/Aids; Human Immunology And Immunotherapy; Infectious Diseases; Inflammation; Transplantation; Vaccine Development

$9,935

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Marcel Behr

Research

Latest papers

Latest funding

Whole genome sequencing of M. tuberculosis for disease control in high-burden settings: study protocol for a cluster randomized controlled trial evaluating different community-wide intervention strategies in rural Madagascar.

Implications of subclinical tuberculosis for vaccine trial design and global effect.

Drivers of Tuberculosis Transmission.

Latent Mycobacterium tuberculosis Infection and Interferon-Gamma Release Assays.

Towards probabilistic decision support in public health practice: predicting recent transmission of tuberculosis from patient attributes.

TB: screening for responses to a vile visitor.

Molecular genetic analysis of two loci (Ity2 and Ity3) involved in the host response to infection with Salmonella typhimurium using congenic mice and expression profiling.

Dwellings, crowding, and tuberculosis in Montreal.

Canada Research Chair - Tier 1

Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)

Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)

Differential virulence within the Mycobacterium tuberculosis complex

The role of the Mycobacterium tuberculosis SigK regulon in infection and disease

Resensitizing bacteria to itaconate as a new approach for the treatment of infections

Initial vancomycin taper for the prevention of recurrent Clostridium difficile infection

Resensitizing intracellular bacteria to itaconate as a new approach for the treatment of Salmonella and Mycobacterial infections

Canada Research Chair Tier 1

From Molecules to Patients to Policies Symposium

Frequent collaborators

Kevin Schwartzman

Philippe Gros

Danielle Malo

David Buckeridge

Erwin Schurr

Paul Brassard

Nancy Ross

David Buckeridge

Madhukar Pai